Critical role of ROCK2 activity in facilitating mucosal CD4+ T cell activation in inflammatory bowel disease

Wenjing Yang, Guangxi Zhou, Tianming Yu, Liang Chen, Lin Yu, Yanmin Guo, Yingzi Cong, Zhanju Liu

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    Rho-associated kinase (ROCK) has been found to be involved in the pathogenesis of a variety of autoimmune diseases, but the role of ROCK in inflammatory bowel disease (IBD) is still elusive. In this study, we demonstrated that the levels of ROCK2, but not ROCK1, activity were significantly upregulated in peripheral blood mononuclear cells (PBMC) and inflamed mucosa from IBD patients using a ROCK activity assay, and that ROCK2 activity in intestinal mucosa was positively correlated with disease severity. Stimulation with TNF markedly upregulated ROCK2 activity in IBD CD4+ T cells through NF-κB signaling. Blockade of ROCK2 activity using Slx-2119 significantly suppressed proinflammatory cytokines in inflamed mucosa from IBD patients including IFX-unresponsive CD patients, and inhibited IBD CD4+ T cells to differentiate into Th1 and Th17 cells through downregulating phosphorylated Stat1 and Stat3, but promoted Treg cell differentiation through upregulating phosphorylated Stat5. Furthermore, oral administration of Slx-2119 markedly ameliorated intestinal mucosal inflammation in TNBS-induced colitis in mice and decreased proinflammatory cytokines productions in inflamed colon. Our data indicate that ROCK2 plays a critical role in inducing mucosal T cell activation and inflammatory responses in IBD and that inhibition of ROCK2 activity might serve as a novel therapeutic approach in the management of IBD.

    Original languageEnglish (US)
    JournalJournal of Autoimmunity
    DOIs
    StateAccepted/In press - Jan 1 2017

    Fingerprint

    Inflammatory Bowel Diseases
    T-Lymphocytes
    rho-Associated Kinases
    Mucous Membrane
    Cytokines
    Th17 Cells
    Th1 Cells
    Regulatory T-Lymphocytes
    Colitis
    Intestinal Mucosa
    Autoimmune Diseases
    Oral Administration
    Cell Differentiation
    Blood Cells
    Colon
    Down-Regulation
    Inflammation

    Keywords

    • IBD
    • ROCK2
    • Slx-2119
    • T cell differentiation

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Immunology

    Cite this

    Critical role of ROCK2 activity in facilitating mucosal CD4+ T cell activation in inflammatory bowel disease. / Yang, Wenjing; Zhou, Guangxi; Yu, Tianming; Chen, Liang; Yu, Lin; Guo, Yanmin; Cong, Yingzi; Liu, Zhanju.

    In: Journal of Autoimmunity, 01.01.2017.

    Research output: Contribution to journalArticle

    Yang, Wenjing ; Zhou, Guangxi ; Yu, Tianming ; Chen, Liang ; Yu, Lin ; Guo, Yanmin ; Cong, Yingzi ; Liu, Zhanju. / Critical role of ROCK2 activity in facilitating mucosal CD4+ T cell activation in inflammatory bowel disease. In: Journal of Autoimmunity. 2017.
    @article{73ea6540286548a28a84e20a372fbc7b,
    title = "Critical role of ROCK2 activity in facilitating mucosal CD4+ T cell activation in inflammatory bowel disease",
    abstract = "Rho-associated kinase (ROCK) has been found to be involved in the pathogenesis of a variety of autoimmune diseases, but the role of ROCK in inflammatory bowel disease (IBD) is still elusive. In this study, we demonstrated that the levels of ROCK2, but not ROCK1, activity were significantly upregulated in peripheral blood mononuclear cells (PBMC) and inflamed mucosa from IBD patients using a ROCK activity assay, and that ROCK2 activity in intestinal mucosa was positively correlated with disease severity. Stimulation with TNF markedly upregulated ROCK2 activity in IBD CD4+ T cells through NF-κB signaling. Blockade of ROCK2 activity using Slx-2119 significantly suppressed proinflammatory cytokines in inflamed mucosa from IBD patients including IFX-unresponsive CD patients, and inhibited IBD CD4+ T cells to differentiate into Th1 and Th17 cells through downregulating phosphorylated Stat1 and Stat3, but promoted Treg cell differentiation through upregulating phosphorylated Stat5. Furthermore, oral administration of Slx-2119 markedly ameliorated intestinal mucosal inflammation in TNBS-induced colitis in mice and decreased proinflammatory cytokines productions in inflamed colon. Our data indicate that ROCK2 plays a critical role in inducing mucosal T cell activation and inflammatory responses in IBD and that inhibition of ROCK2 activity might serve as a novel therapeutic approach in the management of IBD.",
    keywords = "IBD, ROCK2, Slx-2119, T cell differentiation",
    author = "Wenjing Yang and Guangxi Zhou and Tianming Yu and Liang Chen and Lin Yu and Yanmin Guo and Yingzi Cong and Zhanju Liu",
    year = "2017",
    month = "1",
    day = "1",
    doi = "10.1016/j.jaut.2017.12.009",
    language = "English (US)",
    journal = "Journal of Autoimmunity",
    issn = "0896-8411",
    publisher = "Academic Press Inc.",

    }

    TY - JOUR

    T1 - Critical role of ROCK2 activity in facilitating mucosal CD4+ T cell activation in inflammatory bowel disease

    AU - Yang, Wenjing

    AU - Zhou, Guangxi

    AU - Yu, Tianming

    AU - Chen, Liang

    AU - Yu, Lin

    AU - Guo, Yanmin

    AU - Cong, Yingzi

    AU - Liu, Zhanju

    PY - 2017/1/1

    Y1 - 2017/1/1

    N2 - Rho-associated kinase (ROCK) has been found to be involved in the pathogenesis of a variety of autoimmune diseases, but the role of ROCK in inflammatory bowel disease (IBD) is still elusive. In this study, we demonstrated that the levels of ROCK2, but not ROCK1, activity were significantly upregulated in peripheral blood mononuclear cells (PBMC) and inflamed mucosa from IBD patients using a ROCK activity assay, and that ROCK2 activity in intestinal mucosa was positively correlated with disease severity. Stimulation with TNF markedly upregulated ROCK2 activity in IBD CD4+ T cells through NF-κB signaling. Blockade of ROCK2 activity using Slx-2119 significantly suppressed proinflammatory cytokines in inflamed mucosa from IBD patients including IFX-unresponsive CD patients, and inhibited IBD CD4+ T cells to differentiate into Th1 and Th17 cells through downregulating phosphorylated Stat1 and Stat3, but promoted Treg cell differentiation through upregulating phosphorylated Stat5. Furthermore, oral administration of Slx-2119 markedly ameliorated intestinal mucosal inflammation in TNBS-induced colitis in mice and decreased proinflammatory cytokines productions in inflamed colon. Our data indicate that ROCK2 plays a critical role in inducing mucosal T cell activation and inflammatory responses in IBD and that inhibition of ROCK2 activity might serve as a novel therapeutic approach in the management of IBD.

    AB - Rho-associated kinase (ROCK) has been found to be involved in the pathogenesis of a variety of autoimmune diseases, but the role of ROCK in inflammatory bowel disease (IBD) is still elusive. In this study, we demonstrated that the levels of ROCK2, but not ROCK1, activity were significantly upregulated in peripheral blood mononuclear cells (PBMC) and inflamed mucosa from IBD patients using a ROCK activity assay, and that ROCK2 activity in intestinal mucosa was positively correlated with disease severity. Stimulation with TNF markedly upregulated ROCK2 activity in IBD CD4+ T cells through NF-κB signaling. Blockade of ROCK2 activity using Slx-2119 significantly suppressed proinflammatory cytokines in inflamed mucosa from IBD patients including IFX-unresponsive CD patients, and inhibited IBD CD4+ T cells to differentiate into Th1 and Th17 cells through downregulating phosphorylated Stat1 and Stat3, but promoted Treg cell differentiation through upregulating phosphorylated Stat5. Furthermore, oral administration of Slx-2119 markedly ameliorated intestinal mucosal inflammation in TNBS-induced colitis in mice and decreased proinflammatory cytokines productions in inflamed colon. Our data indicate that ROCK2 plays a critical role in inducing mucosal T cell activation and inflammatory responses in IBD and that inhibition of ROCK2 activity might serve as a novel therapeutic approach in the management of IBD.

    KW - IBD

    KW - ROCK2

    KW - Slx-2119

    KW - T cell differentiation

    UR - http://www.scopus.com/inward/record.url?scp=85038629048&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85038629048&partnerID=8YFLogxK

    U2 - 10.1016/j.jaut.2017.12.009

    DO - 10.1016/j.jaut.2017.12.009

    M3 - Article

    JO - Journal of Autoimmunity

    JF - Journal of Autoimmunity

    SN - 0896-8411

    ER -